Manuela Lemmens Email

Administration Assistant . DISCO Pharmaceuticals GmbH

Current Roles

Employees:
31
Revenue:
$6.2M
About
DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.
DISCO Pharmaceuticals GmbH Address

Cologne, null
DE
DISCO Pharmaceuticals GmbH Email